Header Logo

Connection

Kyle Amber to Incidence

This is a "connection" page, showing publications Kyle Amber has written about Incidence.
Connection Strength

0.571
  1. Comment on "Incidence of pneumocystosis among patients exposed to immunosuppression". J Am Acad Dermatol. 2019 08; 81(2):e47.
    View in: PubMed
    Score: 0.135
  2. Determining the Incidence of Pneumocystis Pneumonia in Patients With Autoimmune Blistering Diseases Not Receiving Routine Prophylaxis. JAMA Dermatol. 2017 11 01; 153(11):1137-1141.
    View in: PubMed
    Score: 0.122
  3. Identifying the incidence of rash, Stevens-Johnson syndrome and toxic epidermal necrolysis in patients taking lamotrigine: a systematic review of 122 randomized controlled trials. An Bras Dermatol. 2017 Jan-Feb; 92(1):139-141.
    View in: PubMed
    Score: 0.116
  4. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype. Am J Clin Dermatol. 2016 Feb; 17(1):71-7.
    View in: PubMed
    Score: 0.108
  5. Patients with pemphigus are at an increased risk of developing rheumatoid arthritis: a large-scale cohort study. Immunol Res. 2020 12; 68(6):373-378.
    View in: PubMed
    Score: 0.038
  6. Google Search Trends and Skin Cancer: Evaluating the US Population's Interest in Skin Cancer and Its Association With Melanoma Outcomes. JAMA Dermatol. 2015 Aug; 151(8):903-5.
    View in: PubMed
    Score: 0.026
  7. An increased risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia in US patients with Merkel cell carcinoma versus Australian patients: A clinical clue to a different mechanism of pathogenesis? Australas J Dermatol. 2016 Aug; 57(3):e114-6.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.